ALDRONA 70 (Alendronic acid Tablets 70 mg)

Šalis: Malaizija

kalba: anglų

Šaltinis: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Nusipirk tai dabar

Pakuotės lapelis Pakuotės lapelis (PIL)
12-03-2020
Prekės savybės Prekės savybės (SPC)
31-05-2022

Veiklioji medžiaga:

ALENDRONATE MONOSODIUM SALT TRIHYDRATE

Prieinama:

HEALOL PHARMACEUTICALS SDN. BHD.

INN (Tarptautinis Pavadinimas):

ALENDRONATE MONOSODIUM SALT TRIHYDRATE

Vienetai pakuotėje:

4tablet Tablets; 4 Tablets

Pagaminta:

Aurobindo Pharma Limited

Pakuotės lapelis

                                ALDRONA 70
_Consumer Medication Information Leaflet (RiMUP)_
Alendronic acid Tablets 70 mg
1
WHAT IS IN THIS LEAFLET
1.
What
_ALDRONA 70_
is used for
2.
How
_ALDRONA 70_
works
3.
Before you use
_ALDRONA 70_
4.
How to use
_ALDRONA 70_
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
_ALDRONA 70_
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
11.
Serial number
WHAT IS _ALDRONA 70_ USED FOR
_ALDRONA 70_
is indicated:
•
for treatment of osteoporosis in
postmenopausal women.
•
reduces the risk of spine and hip
fractures.
•
for treatment of osteoporosis in
men to prevent fractures.
HOW _ALDRONA 70_ WORKS
The active ingredient of Alendronate
sodium, is a bisphosphonate that acts
as a potent, specific inhibitor of
osteoclats-mediated bone resorption.
Bisphosphonates are synthetic
analogs of pyrophosphate that binds
to the hydroxyapatite found in the
bone and specifically inhibits
the activity of osteoclats, the bone-
resorbing cells. Alendronate inhibits
osteoclastic bone resorption with no
direct effect on bone formation,
although the latter process is
ultimately reduced because bone
resorption and formations are
coupled during bone turn over.
BEFORE YOU USE _ALDRONA 70_
-
_When you must not use it _
_ _
•
Hypersensitivity to Alendronic
acid or to any of the excipients.
•
Abnormalities of the oesophagus
and other factors which delay
oesophageal emptying such as
stricture or achalasia.
•
Inability to stand or sit upright
for at least 30 minutes.
•
Hypocalcaemia.
-
_Before you start to use it _
_ _
Please make sure you have
understood the explanation given by
your doctor or pharmacist before
taking this medicine. Speak to your
doctor/pharmacist if you have one of
following conditions:
•
kidney problems.
•
swallowing or digestive
problems.
•
Barrett's oesophagus (a
condition associated with
changes in the cells that line the
lower oesophagus).
•
low blood calcium.
•
poor dental health, gum disease,
a planned extraction or you don't
rec
                                
                                Perskaitykite visą dokumentą
                                
                            

Dokumentai kitomis kalbomis

Pakuotės lapelis Pakuotės lapelis malajiečių 12-03-2020

Ieškokite perspėjimų, susijusių su šiuo produktu